Home / Tag Archives: Nasdaq: NTEC

Tag Archives: Nasdaq: NTEC

Healthcare News In Focus: Intec Pharma Ltd. (Nasdaq: NTEC, TASE: NTEC)

Intec Pharma Ltd. (Nasdaq: NTEC, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, declares the appointment of Jeffrey A. Meckler as Chief Executive Officer, effective right away. Mr. Meckler was named Vice Chairman of the Intec Pharma Board of …

Read More »